Table 1 Antimicrobial resistance profiles of MRSA, MSSA, and S. aureus isolates
Antibiotics | Group1 | Group2 | S. aureus | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRSAa (n = 61) | MSSAb (n = 99) | MRSA (n = 99) | MSSA (n = 91) | Group 1 (n = 160) | Group 2 (n = 190) | |||||||||||||
Rc | Id | Se | R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | |
Penicillin | 61 | 0 | 0 | 68 | 0 | 31 | 99 | 0 | 0 | 70 | 0 | 21 | 129 | 0 | 31 | 169 | 0 | 21 |
Tetracycline | 58 | 2 | 1 | 21 | 9 | 69 | 64 | 2 | 33 | 40 | 9 | 42 | 79 | 11 | 70 | 104 | 11 | 75 |
Clindamycin | 49 | 4 | 8 | 35 | 9 | 55 | 69 | 4 | 26 | 28 | 2 | 61 | 84 | 13 | 63 | 97 | 6 | 87 |
Gentamicin | 59 | 0 | 2 | 32 | 8 | 59 | 79 | 11 | 9 | 9 | 8 | 74 | 91 | 8 | 61 | 88 | 19 | 83 |
Ciprofloxacin | 55 | 5 | 1 | 33 | 12 | 54 | 94 | 2 | 3 | 27 | 1 | 63 | 88 | 17 | 55 | 121 | 3 | 66 |
Erythromycin | 47 | 3 | 11 | 22 | 9 | 71 | 58 | 6 | 35 | 50 | 0 | 41 | 50 | 9 | 82 | 108 | 6 | 76 |
Chloramphenicol | 57 | 0 | 4 | 40 | 11 | 48 | 83 | 7 | 9 | 15 | 4 | 72 | 97 | 11 | 52 | 98 | 11 | 81 |
Linezolid | 4 | 0 | 57 | 0 | 0 | 99 | 6 | 0 | 93 | 1 | 0 | 90 | 4 | 0 | 156 | 7 | 0 | 183 |
Trimethoprim/sulfamethoxazole | 27 | 3 | 31 | 22 | 1 | 76 | 37 | 6 | 56 | 14 | 3 | 74 | 49 | 4 | 107 | 51 | 9 | 130 |
Rifampicin | 7 | 0 | 54 | 4 | 0 | 95 | 8 | 0 | 91 | 1 | 0 | 90 | 11 | 0 | 149 | 9 | 0 | 181 |
MIC (µg/ml) | ||||||||||||||||||
 Vancomycin | 0 | 2 | 59 | 0 | 0 | 99 | 0 | 4 | 95 | 0 | 0 | 91 | 0 | 2 | 158 | 0 | 4 | 186 |
 Oxacillin | 59 | 2 | 0 | 0 | 0 | 99 | 98 | 1 | 0 | 0 | 0 | 91 | 59 | 9 | 92 | 98 | 4 | 88 |
 Cefoxitin | 61 | 0 | 0 | 0 | 0 | 99 | 99 | 0 | 0 | 0 | 0 | 91 | 61 | 11 | 88 | 99 | 5 | 86 |